The Indian government is challenging the Adani Group’s attempt to overturn a ruling against the sale of nicotine pouches at Mumbai International Airport. Authorities state these sales violate drug laws and pose health risks, arguing that airport duty-free shops remain subject to Indian territory regulations.
The Indian government has formally opposed the Adani Group’s legal effort to challenge a finding that the sale of nicotine pouches at Mumbai’s Chhatrapati Shivaji Maharaj International Airport (CSMIA) is illegal. In recent court filings, state authorities characterized the stocking and sale of these products as a significant violation of national drug laws, emphasizing the potential for adverse public health consequences.
Conflict Over Territorial Jurisdiction
At the center of the dispute is the question of whether Indian drug regulations apply within the airport’s customs-bonded areas. The Adani Group, which operates the Mumbai airport, has argued that its duty-free sales of these products to international passengers occur outside the scope of domestic Indian law. However, government representatives have countered this in court, asserting that because the products arrive and are physically stored within the airport—which sits on Indian soil—they are subject to the same regulatory oversight as any other product in the country.
This case originated following a March inspection by the national drugs department, which discovered that duty-free outlets at the airport were selling nicotine pouches without the mandatory government approvals. While the Adani Group has maintained that these pouches are a new product category that should not be classified under standard drug definitions, the government has categorized nicotine as a psychoactive and addictive chemical.
Regulatory Impact and Public Health Policy
This legal battle carries broader implications for the regulation of nicotine delivery systems in India. Since the 2019 ban on e-cigarettes and similar vaping products, the government has maintained a strict stance on unregulated nicotine items. Officials have pointed to the rising popularity of these pouches among younger demographics, particularly those aged 18 to 40, as a growing public health concern. The government argues that allowing such sales would effectively bypass existing legislative policies designed to curb nicotine addiction and tobacco-related health issues, which contribute to over one million deaths in India annually.
For the Adani Group, the outcome of this litigation is significant given its extensive involvement in the airport infrastructure and retail sector. The group currently operates eight airports across India and has been looking to expand its duty-free and commercial retail footprint. Investors may monitor this case for potential impacts on the company’s retail operations and its compliance strategies at other airport locations. The next steps will involve further court proceedings where the judiciary will decide whether the specific legal status of customs-bonded warehouses exempts these products from Indian drug laws.